Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled ...

Acquisition Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, to Sun Pharma's Global ... The U.S. Food and Drug Administration recently ...

Through a regulatory filing, Sun Pharmaceutical Industries has announced its acquisition of Concert Pharmaceuticals, a late-stage clinical biopharmaceutical company that is developing ...

Drug major Sun Pharma on Monday said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to acquire Concert in a USD 576 million ...

MUMBAI, India and PRINCETON, N.J., March 6, 2023 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters ... inhibitor of Janus kinases JAK1 and JAK2. The U.S. Food and Drug Administration ...

Alembic Pharmaceuticals Limited (Alembic) announced it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) fluorouracil injection ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA issued an import alert Tuesday to clamp down on the illegal importation of xylazine, an animal tranquilizer ...

Other drug makers, Dr Reddy's Laboratories and Lupin both reported cyber security breaches in 2020. At around 10.05 AM, Sun Pharma was trading 0.27% lower at Rs962.65, against the previous close ...